Kate Priestman

Kate Priestman is currently the Chief Corporate & External Affairs Officer at CSL and serves as a Senior Independent Director and Non-Executive Director at Oxford Nanopore Technologies. With extensive experience at GSK since June 2015, Kate holds the position of Senior Vice President, responsible for Strategy, Portfolio Management, and Operations in R&D. Additionally, Kate is a Trustee of the Royal Botanic Gardens, Kew, and has held various roles within GSK, including Vice President of Corporate Strategy and Head of the CEO's Future Strategy Group, among others. Prior experience includes leadership positions at Eli Lilly and AstraZeneca, complemented by an early career as a presenter at the BBC. Kate has an academic background from Nottingham University, Stanford University Graduate School of Business, and UCL.